Which RNA-Targeted Drug Discovery Leaders Are Attending in 2026?
Discover the companies joining the 9th RNA-Targeted Drug Discovery & Development Summit 2026. Featuring organisations represented by our speakers and delegates, these companies reflect the diverse ecosystem of biotech pioneers, pharmaceutical innovators, and academic researchers united in accelerating the discovery and development of RNA-targeted therapies.
Arrakis Therapeutics
AstraZeneca
Atomic AI
Bayer
CHDI
Dewpoint Therapeutics
Eli Lilly & Co.
EPICS Therapeutics
Mol Horizon
Nippon Shinyaku Co., Ltd.
Pfizer
PTC Therapeutics
Remix Therapeutics
Renasis Bio
ReviR Therapeutics
RevoNA
Ribometrix
Ribonaut Therapeutics
Sanofi
Schrodinger Inc
Syrna Therapeutics
UNC Chapel Hill
University of Colorado Boulder
University of Toronto
University of Wisconsin–Madison
Wayfinder Biosciences
Take Advantage of Group Discounts:
